Pretransplant Fecal Carriage of Extended-Spectrum β-Lactamase–producingEnterobacteriaceaeand Infection after Liver Transplant, France
Authors:
- Frédéric BertFBFrédéric Bert
- Béatrice LarroqueBLBéatrice Larroque
- Catherine Paugam-BurtzCPCatherine Paugam-Burtz
- Federica DonderoFDFederica Dondero
- François DurandFDFrançois Durand
- Estelle MarconEMEstelle Marcon
- Jacques BelghitiJBJacques Belghiti
- Richard MoreauRMRichard Moreau
- Marie-Hélène Nicolas-ChanoineMNMarie-Hélène Nicolas-Chanoine
Open Access
- 1 June 2012
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 18 (6) , 908-916
Abstract
Extended-spectrum β-lactamase–producing Enterobacteriaceae isolates (ESBLE) are emerging pathogens that confer resistance to antimicrobial drugs. We conducted a 10-year study in France (January 2001–April 2010) to investigate the incidence of and risk factors for ESBLE infections after liver transplant. Of 710 transplant patients screened preoperatively for ESBLE fecal carriage, 5.5% had ESBLE infection develop within 4 months after surgery; patients with pretransplant ESBLE fecal carriage were more likely to have infection develop than were noncarriers. Typing showed extensive genetic diversity, with a large predominance of CTX-M enzymes. Independent predictors of ESBLE infection were pretransplant fecal carriage, Model for End Stage Liver Disease score >25, and return to surgery. Our results indicate that the influx of preoperatively acquired ESBLE isolates into the hospital outweighs cross-transmission in the epidemiology of ESBLE infections after liver transplant. Transplant candidates should be systematically screened for carriage, and posttransplant infection in carriers should be treated with carbapenems.Keywords
This publication has 35 references indexed in Scilit:
- Comparison of Nine Phenotypic Methods for Detection of Extended-Spectrum β-Lactamase Production by EnterobacteriaceaeJournal of Clinical Microbiology, 2011
- Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignanciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Evaluation of a DNA Microarray, the Check-Points ESBL/KPC Array, for Rapid Detection of TEM, SHV, and CTX-M Extended-Spectrum β-Lactamases and KPC CarbapenemasesAntimicrobial Agents and Chemotherapy, 2010
- Genetic Diversity and Virulence Profiles of Escherichia coli Isolates Causing Spontaneous Bacterial Peritonitis and Bacteremia in Patients with CirrhosisJournal of Clinical Microbiology, 2010
- Evaluation of a Commercial Microarray System for Detection of SHV-, TEM-, CTX-M-, and KPC-Type β-Lactamase Genes in Gram-Negative IsolatesJournal of Clinical Microbiology, 2010
- Risk Factors and Prognosis of Nosocomial Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coliJournal of Clinical Microbiology, 2010
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concernThe Lancet Infectious Diseases, 2008
- Risk Factors for Colonization with Extended-Spectrum β-Lactamase–producing Bacteria and Intensive Care Unit AdmissionEmerging Infectious Diseases, 2007
- Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae : Importance of Inadequate Initial Antimicrobial TreatmentAntimicrobial Agents and Chemotherapy, 2007
- Clinical and Economic Impact of Bacteremia with Extended- Spectrum-β-Lactamase-Producing EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 2006